|
|
Volumn 37, Issue 5, 2002, Pages 355-366
|
|
Novel substituted quinoxaline 1,4-dioxides with in vitro antimycobacterial and anticandida activity
a
a
a
a
|
|
Author keywords
Antibacterial activity; Anticandida; Antimycobacterial; Quinoxaline 1,4 dioxides
|
|
Indexed keywords
2 CHLORO 3,6 DIMETHYLQUINOXALINE 1,4 DIOXIDE;
2 CHLORO 6,7 DIFLUORO 3 METHYLQUINOXALINE 1,4 DIOXIDE;
2 CHLORO 7 ETHOXY 6 FLUORO 3 METHYLQUINOXALINE 1,4 DIOXIDE;
2,7 DICHLORO 3 METHYLQUINOXALINE 1,4 DIOXIDE;
3 BROMOMETHYL 6 CHLORO 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
3 BROMOMETHYL 7 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
3 BROMOMETHYL 7 TRIFLUOROMETHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
3 METHYL 2 PHENYLSULFONYLQUINOXALINE 1,4 DIOXIDE;
3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
3,6 DIMETHYL 2 PHENYLSULFONYLQUINOXALINE 1,4 DIOXIDE;
6 CHLORO 3 METHYL 2 PHENYLSULFONYLQUINOXALINE 1,4 DIOXIDE;
6 CHLORO 3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
6 TRIFLUOROMETHYL 3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
6,7 DIFLUORO 3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
7 CHLORO 3 METHYL 2 PHENYLSULFONYLQUINOXALINE 1,4 DIOXIDE;
7 CHLORO 3 METHYL 2 PHENYLTHIOQUINOXALINE 1,4 DIOXIDE;
ANTIMYCOBACTERIAL AGENT;
MICONAZOLE;
QUINOXALINE DERIVATIVE;
RIFAMPICIN;
UNCLASSIFIED DRUG;
ANTIBACTERIAL ACTIVITY;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
CANDIDA;
CANDIDA GLABRATA;
CANDIDA KRUSEI;
CONTROLLED STUDY;
DRUG SCREENING;
DRUG SYNTHESIS;
MINIMUM INHIBITORY CONCENTRATION;
MYCOBACTERIUM TUBERCULOSIS;
NONHUMAN;
VIBRIO ALGINOLYTICUS;
ANTI-BACTERIAL AGENTS;
ANTI-INFECTIVE AGENTS;
ANTIFUNGAL AGENTS;
ANTITUBERCULAR AGENTS;
CANDIDA;
GRAM-NEGATIVE BACTERIA;
GRAM-POSITIVE BACTERIA;
MICROBIAL SENSITIVITY TESTS;
MYCOBACTERIUM TUBERCULOSIS;
QUINOXALINES;
|
|
EID: 0036242821
PISSN: 02235234
EISSN: None
Source Type: Journal
DOI: 10.1016/S0223-5234(02)01346-6 Document Type: Article |
|
Times cited : (142)
|
|
References (42)
|
